Terms: = Colorectal cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Clinical Outcome
3 results:
1. CD8
E J; Yan F; Kang Z; Zhu L; Xing J; Yu E
Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815
[TBL] [Abstract] [Full Text] [Related]
2. Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients.
Jun L; Haiping Z; Beibei Y
Swiss Med Wkly; 2009 Dec; 139(49-50):724-8. PubMed ID: 20047135
[TBL] [Abstract] [Full Text] [Related]
3. Molecular determinants of irinotecan efficacy.
Vallböhmer D; Iqbal S; Yang DY; Rhodes KE; Zhang W; Gordon M; Fazzone W; Schultheis AM; Sherrod AE; Danenberg KD; Lenz HJ
Int J Cancer; 2006 Nov; 119(10):2435-42. PubMed ID: 16894565
[TBL] [Abstract] [Full Text] [Related]
